These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21269004)

  • 1. A retrospective chart review of opioid-induced nausea and somnolence on commencement for cancer pain treatment.
    Okamoto Y; Tsuneto S; Tsugane M; Takagi T; Uejima E
    J Opioid Manag; 2010; 6(6):431-4. PubMed ID: 21269004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients.
    Yamada T; Kanazawa Y; Aoki Y; Uchida E
    J Nippon Med Sch; 2015; 82(2):100-5. PubMed ID: 25959201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
    Tsukuura H; Miyazaki M; Morita T; Sugishita M; Kato H; Murasaki Y; Gyawali B; Kubo Y; Ando M; Kondo M; Yamada K; Hasegawa Y; Ando Y
    Oncologist; 2018 Mar; 23(3):367-374. PubMed ID: 29038236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
    Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
    Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study on the antiemetic effect and extrapyramidal symptoms of prochlorperazine versus perospirone for the control of nausea and vomiting due to opioid introduction].
    Yomiya K; Takei D; Kurosawa H; Kono B
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1037-41. PubMed ID: 23986047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of Transdermal Fentanyl in a Hospital].
    Sako A; Yoshikawa Y; Kikuchi N; Watanabe A; Yoshida S
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):341-4. PubMed ID: 27067851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Validity of recommended minimum dose of prior morphine to initiate transdermal fentanyl patch in prescribing information - multicenter survey of on prescriptions by palliative care specialists in Japan].
    Hashizume T; Tomiyasu S; Yomiya K; Yoshimoto T; Harada A; Matoba M;
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):897-902. PubMed ID: 17570968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Analgesic Efficacy and Safety of Low-Dose Transdermal Fentanyl and Oral Oxycodone in Opioid-Naïve Patients with Cancer Pain.
    Kawana M; Miyasato A; Funato M; Nagatani K; Suzuki N; Onoda C; Fujimoto H; Ohno R; Kusakabe A; Kiribayashi M; Nakamura K; Kondo M; Ozeki A; Okamoto K; Kokubun H
    Biol Pharm Bull; 2023; 46(10):1444-1450. PubMed ID: 37779046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain.
    Wong JO; Chiu GL; Tsao CJ; Chang CL
    Acta Anaesthesiol Sin; 1997 Mar; 35(1):25-32. PubMed ID: 9212478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B; Ross E; Sasaki J; Weil A
    Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of controlled-release oxycodone 20 mg administered on a 12-h dosing schedule on the management of postoperative pain after breast surgery for cancer.
    Kampe S; Warm M; Kaufmann J; Hundegger S; Mellinghoff H; Kiencke P
    Curr Med Res Opin; 2004; 20(2):199-202. PubMed ID: 15006014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of transdermal fentanyl for the management of cancer pain in adults and elders].
    Bilen A; Ali A; Alkan I; Altan A
    Agri; 2012; 24(3):111-6. PubMed ID: 22865517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe pain.
    Kang JH; Oh SY; Song SY; Lee HY; Kim JH; Lee KE; Lee HR; Hwang IG; Park SH; Kim WS; Park YS; Park K
    Korean J Intern Med; 2015 Jan; 30(1):88-95. PubMed ID: 25589840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of transdermal fentanyl patches for opioid initiation in patients with gastrointestinal obstruction].
    Miyoshi T; Yamauchi H; Misumi N; Goto T; Kai S; Yoshida E; Nishino T; Hasuo Y
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1401-5. PubMed ID: 25434443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
    Portenoy RK; Payne R; Coluzzi P; Raschko JW; Lyss A; Busch MA; Frigerio V; Ingham J; Loseth DB; Nordbrock E; Rhiner M
    Pain; 1999 Feb; 79(2-3):303-12. PubMed ID: 10068176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strong opioids and constipation].
    Schwarzer A; Nauck F; Klaschik E
    Schmerz; 2005 Jun; 19(3):214-9. PubMed ID: 15004747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.
    Reddy A; Tayjasanant S; Haider A; Heung Y; Wu J; Liu D; Yennurajalingam S; Reddy S; de la Cruz M; Rodriguez EM; Waletich J; Vidal M; Arthur J; Holmes C; Tallie K; Wong A; Dev R; Williams J; Bruera E
    Cancer; 2016 Jan; 122(1):149-56. PubMed ID: 26451687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.